Overview

Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)

Status:
Completed

Trial end date:
2021-03-31

Target enrollment:

Participant gender:

Summary

The main objective of the CIRCULATE project is to compare the clinical outcomes of CardioCell administration in treatment of ischemic damages of cardiovascular system with control group, who will receive the placebo.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

John Paul II Hospital, Krakow

Collaborators:

KCRI
National Center for Research and Development, Poland